HOOKIPA Pharma (NASDAQ:HOOK) Shares Down 0% – Here’s What Happened

HOOKIPA Pharma Inc. (NASDAQ:HOOK) shares traded down 0% during trading on Tuesday . The company traded as low as $1.01 and last traded at $1.01. 526 shares changed hands during trading, a decline of 94% from the average session volume of 8,102 shares. The stock had previously closed at $1.0101.

HOOKIPA Pharma Price Performance

The firm has a market cap of $12.31 million, a PE ratio of -0.17 and a beta of 0.92. The business has a 50-day moving average price of $0.96 and a two-hundred day moving average price of $0.91.

HOOKIPA Pharma Company Profile

HOOKIPA Pharma Inc is a clinical-stage biotechnology company focused on the development of virus-based immunotherapies and vaccines. The company operates two complementary platform technologies—an engineered Modified Vaccinia Ankara (MVA) vector and an arenavirus vector system—designed to stimulate both humoral and cellular immune responses. By combining these platforms, HOOKIPA aims to address infectious diseases and drive novel immuno-oncology treatments.

In the infectious disease arena, HOOKIPA’s pipeline includes prophylactic vaccine candidates targeting pathogens such as cytomegalovirus (CMV) in transplant settings and other viral threats.